Literature DB >> 9554747

Frequent mutation in Chinese patients with infantile type of GSD II in Taiwan: evidence for a founder effect.

J J Shieh1, C Y Lin.   

Abstract

Glycogen storage disease type II (GSD II, Pompe's disease), an autosomal recessive inherited disease, is caused by the deficiency of acid alpha-D-glucosidase, which results in the impaired glycogen degradation in lysosome and causes excess glycogen accumulation in lysosome. In Taiwan, the infantile form of GSD II is the most common type of glycogen storage diseases. The frequency of C1935A mutant allele is 0.8 in these Chinese patients. In this study, we analyzed four single point polymorphic markers (324, 1203, 2065, 2338) by ACRS-based RFLP We observed that the alleles possessing the C1935A mutation in 19 of 25 Chinese patients who were heterozygous or homozygous have conserved polymorphic markers, and all of C1935A mutant alleles in these patients are linked to a specific haplotype. The allele frequency of this specific haplotype in 19 Chinese patients and in 42 normal individuals is 0.95 and 0.17, respectively (P<0.005, chi2 = 66.018). This result suggests that the C1935A mutation in Chinese patients with infantile form of GSD II is due to the founder effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9554747     DOI: 10.1002/(SICI)1098-1004(1998)11:4<306::AID-HUMU8>3.0.CO;2-S

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  10 in total

Review 1.  Pompe Disease: From Basic Science to Therapy.

Authors:  Lara Kohler; Rosa Puertollano; Nina Raben
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

2.  Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy.

Authors:  Nina Raben; Evelyn Ralston; Yin-Hsiu Chien; Rebecca Baum; Cynthia Schreiner; Wuh-Liang Hwu; Kristien J M Zaal; Paul H Plotz
Journal:  Mol Genet Metab       Date:  2010-08-07       Impact factor: 4.797

3.  Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II.

Authors:  L Wan; C-C Lee; C-M Hsu; W-L Hwu; C-C Yang; C-H Tsai; F-J Tsai
Journal:  J Neurol       Date:  2008-05-06       Impact factor: 4.849

4.  Structural and biochemical studies on Pompe disease and a "pseudodeficiency of acid alpha-glucosidase".

Authors:  Youichi Tajima; Fumiko Matsuzawa; Sei-Ichi Aikawa; Toshika Okumiya; Michiru Yoshimizu; Takahiro Tsukimura; Masahiko Ikekita; Seiichi Tsujino; Akihiko Tsuji; Tim Edmunds; Hitoshi Sakuraba
Journal:  J Hum Genet       Date:  2007-09-06       Impact factor: 3.172

5.  Infantile Pompe disease: A case report and review of the Chinese literature.

Authors:  Yun Liu; Yang Yang; Beibei Wang; Lizhi Wu; Honglu Liang; Qing Kan; Zhaolan Cao; Youyan Zhao; Xiaoyu Zhou
Journal:  Exp Ther Med       Date:  2015-11-12       Impact factor: 2.447

6.  A novel homozygous mutation at the GAA gene in Mexicans with early-onset Pompe disease.

Authors:  Carmen Esmer; Rosario Becerra-Becerra; Claudia Peña-Zepeda; Antonio Bravo-Oro
Journal:  Acta Myol       Date:  2013-10

Review 7.  Pompe disease: from pathophysiology to therapy and back again.

Authors:  Jeong-A Lim; Lishu Li; Nina Raben
Journal:  Front Aging Neurosci       Date:  2014-07-23       Impact factor: 5.750

8.  Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand.

Authors:  Lukana Ngiwsara; Duangrurdee Wattanasirichaigoon; Thipwimol Tim-Aroon; Kitiwan Rojnueangnit; Saisuda Noojaroen; Arthaporn Khongkraparn; Phannee Sawangareetrakul; James R Ketudat-Cairns; Ratana Charoenwattanasatien; Voraratt Champattanachai; Chulaluck Kuptanon; Suthipong Pangkanon; Jisnuson Svasti
Journal:  BMC Med Genet       Date:  2019-09-11       Impact factor: 2.103

9.  Broad variation in phenotypes for common GAA genotypes in Pompe disease.

Authors:  Monica Y Niño; Stijn L M In't Groen; Douglas O S de Faria; Marianne Hoogeveen-Westerveld; Hannerieke J M P van den Hout; Ans T van der Ploeg; Atze J Bergsma; W W M Pim Pijnappel
Journal:  Hum Mutat       Date:  2021-09-08       Impact factor: 4.700

10.  A New Mutation Causing Severe Infantile-Onset Pompe Disease Responsive to Enzyme Replacement Therapy.

Authors:  Hossein Moravej; Anis Amirhakimi; Alireza Showraki; Hamid Amoozgar; Zahra Hadipour; Ghasem Nikfar
Journal:  Iran J Med Sci       Date:  2018-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.